Search

NMR structure of the Bak transmembrane helix in lipid nanodiscs
Authors
Sperl, L.E., Hagn, F.
Assembly
Bcl-2 homologous antagonist/killer
Entity
1. Bcl-2 homologous antagonist/killer (polymer, Thiol state: not present), 30 monomers, 3241.910 Da Detail

SLGNGPILNV LVVLGVVLLG QFVVRRFFKS


Formula weight
3241.91 Da
Source organism
Homo sapiens
Exptl. method
solution NMR
Data set
assigned_chemical_shifts, spectral_peak_list
Chem. Shift Complete
Sequence coverage: 80.0 %, Completeness: 21.8 %, Completeness (bb): 52.2 % Detail

Polymer type: polypeptide(L)

Total1H15N
All21.8 % (48 of 220)12.9 % (24 of 186)70.6 % (24 of 34)
Backbone52.2 % (48 of 92)38.1 % (24 of 63)82.8 % (24 of 29)
Sidechain 0.0 % (0 of 128) 0.0 % (0 of 123) 0.0 % (0 of 5)
Aromatic 0.0 % (0 of 15) 0.0 % (0 of 15)
Methyl 0.0 % (0 of 28) 0.0 % (0 of 28)

1. entity 1

SLGNGPILNV LVVLGVVLLG QFVVRRFFKS

Sample

Solvent system 95% H2O/5% D2O, Pressure 1 atm, Temperature 315 K, pH 7.0, Details 400 uM [U-13C; U-15N; U-2H] Bak transmembrane helix, 20 mM sodium phosphate, 50 mM sodium chloride, 1 mM EDTA, 95% H2O/5% D2O


#NameIsotope labelingTypeConcentration
1Bak transmembrane helix[U-13C; U-15N; U-2H]400 uM
2sodium phosphatenatural abundance20 mM
3sodium chloridenatural abundance50 mM
4EDTAnatural abundance1 mM

Release date
2021-06-10
Citation
High-resolution analysis of the conformational transition of pro-apoptotic Bak at the lipid membrane
Sperl, L.E., Ruhrnossl, F., Schiller, A., Haslbeck, M., Hagn, F.
EMBO J. (2021), 40, e107159-e107159, PubMed 34523144 , DOI 10.15252/embj.2020107159 ,
Related entities 1. Bcl-2 homologous antagonist/killer, : 1 : 1 : 2 : 4 entities Detail
Interaction partners 1. Bcl-2 homologous antagonist/killer, : 43 interactors Detail
Experiments performed 3 experiments Detail
Chemical shift validation 3 contents Detail
Keywords APOPTOSIS, Bcl2 proteins, mitochondria, pore formation